Life-threatening hemophagocytic syndromes: Current outcomes with hematopoietic stem cell transplantation

Pediatric Transplantation

Volumn 9, Issue SUPPL. 7, 2005, Pages 87-91

  Filipovich, Alexandra H ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Hemophagocytic lymphohistiocytosis; Stem cell transplantation

Indexed keywords

ETOPOSIDE; STEROID;

ALLOGENEIC STEM CELL TRANSPLANTATION; CLINICAL TRIAL; CONFERENCE PAPER; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOPHAGOCYTIC SYNDROME; HUMAN; LABORATORY TEST; NATURAL KILLER CELL; PHYSICAL EXAMINATION;

ADRENAL CORTEX HORMONES; ANTI-INFLAMMATORY AGENTS; ANTINEOPLASTIC AGENTS; CHILD; DIAGNOSIS, DIFFERENTIAL; ETOPOSIDE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; KILLER CELLS, NATURAL; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 28344436688     PISSN: 13973142     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2005.00449.x     Document Type: Conference Paper

References (10)

1. HENTER J-I, BLINDER G, SODER O, OST A. Incidence in Sweden and clinical features of familial hemophagocytic lymphohistiocytosis. Acta Paediatr Scand 1991: 80: 428-435.
2. EGELER M, SHAPIRO R, LOECHELT BJ, FILIPOVICH AH. Characteristic immune abnormalities in hemophagocytic lymphohistiocytosis. Am J Fed Hem Onc 1996: 18: 340-345.
3. SCHNEIDER EM, LORENZ I, MULLER-ROSENBERGER M, STEINBACH G, KRON M, JANKA-SCHAUB GE. Hemophagocytic lymphohistiocytosis is associated with deficiencies of cellular cytolysis but normal expression of transcripts relevant to killer cell-induced apoptosis. Blood 2002: 100: 2891-2898.
4. STEPP SE, DUFOURCQ-LAGELOUSE R, LE DEIST F, et al. Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science 1999: 286: 1957-1959.
5. FELDMANN J, CALLEBAUT I, RAPOSO G, et al. Munc 13-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3). Cell 2003: 115: 461-473.
6. FILIPOVICH AH. Hemophagocytic lymphohistiocytosis. Allergy and immunology clinics of North America. J Pediatr 2002: 130: 337-338.
7. MOLLERAN LEE S, VILLANUEVA J, SUMEGI J, et al. Characterisation of diverse PRF1 mutations leading to decreased natural killer cell activity in North American families with haemophagocytic lymphohistiocytosis. J Med Genet 2004: 41: 137-144.
8. KOGAWA K, LEE SM, VILLANUEVA J, MARMER D, SUMEGI J, FILIPOVICH AH. Perforin expression in cytotoxic lymphocytes from patients with hemophagocytic lymphohistiocytosis and their family members. Blood 2002: 99: 61-66.
9. HENTER J-I, SAMUELSSON-HORNE AC, ARISO M, et al. Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Blood 2002: 100: 2367-2373.
10. HORNE AC, JANKA G, EGELER RM, et al. Hematopoietic stem cell transplantation in hemophagocytic lymphohistiocytosis. Br J Hematol 2005: 129: 622-30.